Prices are updated after-hours


Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date

tags : Approval    save search

NeuroSense Receives Approval in Germany to Enroll Patients in its Phase 2b ALS Trial
Published: 2023-02-08 (Crawled : 14:20) - prnewswire.com
NRSN | News | $1.72 12.42% 680K twitter stocktwits trandingview |
| Email alert Add to watchlist

enroll als trial approval germany
Annovis Bio Announces Approval for European Union Clinical Trial Sites for the Phase 3 Study of Buntanetap for the Treatment of Parkinson's Disease
Published: 2023-02-08 (Crawled : 13:00) - prnewswire.com
ANVS | News | $19.175 1.35% 30K twitter stocktwits trandingview |
Health Technology
| | O: 1.1% H: 0.0% C: 0.0%

treatment disease for parkinson's buntanetap trial approval study
ADMA BioCenters Receives FDA Approval for its Eighth Plasma Collection Center, Located in Hammond, LA
Published: 2023-02-08 (Crawled : 12:00) - admabiologics.com
ADMA | News | $3.81 -1.3% 890K twitter stocktwits trandingview |
Health Technology
| | O: 1.74% H: 0.0% C: 0.0%

fda for approval
Opiant Pharmaceuticals Announces CFIUS Approval for Proposed Acquisition by Indivior PLC
Published: 2023-02-07 (Crawled : 23:00) - biospace.com/
OPNT | News | $21.115 0.4% 64K twitter stocktwits trandingview |
Health Technology
| | O: -0.38% H: 0.0% C: 0.0%

acquisition pharmaceuticals for approval
Kiora Pharmaceuticals Receives Investigational New Drug Approval for Phase 2 Study of KIO-101 for Treatment of Ocular Presentation of Autoimmune Diseases
Published: 2023-02-07 (Crawled : 15:00) - biospace.com/
KPRX | News | $6.43 41.32% 16M twitter stocktwits trandingview |
Manufacturing
| | O: 64.94% H: 0.0% C: 0.0%

kio-101 treatment pharmaceuticals drug for ocular approval presentation study
LanzaTech Announces AMCI Stockholder Approval for their Business Combination as well as Additional PIPE Investments and Forward Purchase Agreement – Yahoo Finance
Published: 2023-02-07 (Crawled : 02:00) - spacfeed.com
FST | News 0 d | $10.18 0.2% twitter stocktwits trandingview |
Finance
| Email alert Add to watchlist

investments for approval agreement
LanzaTech Announces AMCI Stockholder Approval for their … – GlobeNewswire
Published: 2023-02-07 (Crawled : 01:00) - spacfeed.com
FST | News 0 d | $10.18 0.2% twitter stocktwits trandingview |
Finance
| Email alert Add to watchlist

for approval
LumiraDx Receives FDA Emergency Use Authorization and UK CTDA Approval for its Fast Lab Solutions Multiplex COVID and Influenza Molecular Assay
Published: 2023-02-06 (Crawled : 16:00) - biospace.com/
LMDX | $1.21 0.83% 46K twitter stocktwits trandingview |
| | O: 26.17% H: 0.76% C: -9.09%

fda covid solutions for approval authorization molecular influenza
Bioxytran Receives Approval to Initiate Trials with ProLectin-I
Published: 2023-02-06 (Crawled : 16:00) - biospace.com/
BIXT | $0.4201 0 twitter stocktwits trandingview |
Professional, Scientific, and T...
| Email alert Add to watchlist

trials approval
Aesther and Ocean Biomedical Announce Shareholder Approval of Business Combination
Published: 2023-02-06 (Crawled : 14:20) - globenewswire.com
AEHA | $11.67 490 twitter stocktwits trandingview |
| | O: 0.55% H: 21.97% C: 17.54%

approval
COMEX recommends the approval of Hydro-Québec’s connection and power line relocation project to Power the Rose Lithium-Tantalum Project
Published: 2023-02-06 (Crawled : 11:00) - cecorp.ca
LTUM | News | $0.126 0 twitter stocktwits trandingview |
Mining, Quarrying, and Oil and ...
| Email alert Add to watchlist
CRECF | $2.16 0 twitter stocktwits trandingview |
Process Industries
| Email alert Add to watchlist

approval
Sizzle Acquisition Corp. Announces Approval of Extension of … – Business Wire
Published: 2023-02-02 (Crawled : 03:00) - spacfeed.com
CETYD new | $5.27 0 twitter stocktwits trandingview |
n/a
| Email alert Add to watchlist
CETY | $0.1119 0 twitter stocktwits trandingview |
Manufacturing
| Email alert Add to watchlist
DTRT | $10.335 -0.15% 0.0% 3K twitter stocktwits trandingview |
| Email alert Add to watchlist

acquisition extension approval
GreenLight Biosciences receives approval to initiate Phase I/II clinical trial of Covid-19 mRNA vaccine candidate
Published: 2023-02-01 (Crawled : 14:00) - biospace.com/
GRNA | $1.015 -3.33% 71K twitter stocktwits trandingview |
Professional, Scientific, and T...
| | O: 9.76% H: 0.0% C: -5.87%

covid-19 candidate vaccine mrna trial approval
Edesa Biotech Receives Regulatory Approval for Phase 2 Vitiligo Study
Published: 2023-02-01 (Crawled : 14:00) - biospace.com/
EDSA | $1.36 -0.73% 26K twitter stocktwits trandingview |
Health Technology
| | O: -0.67% H: 1.85% C: -5.37%

for biotech approval study phase 2
Cybin Announces Approval of First-in-Human Dosing of its Proprietary DMT Molecule CYB004
Published: 2023-02-01 (Crawled : 13:00) - biospace.com/
CYBN | $0.431 -4.22% 1.9M twitter stocktwits trandingview |
n/a
| | O: -0.51% H: 15.98% C: 12.35%

cyb004 approval
Pan American Receives Shareholder Approval Regarding the Proposed Arrangement with Yamana and Agnico Eagle
Published: 2023-01-31 (Crawled : 22:00) - prnewswire.com
AUY | $5.73 0.18% 3M twitter stocktwits trandingview |
Non-Energy Minerals
| | O: -0.66% H: 3.51% C: 2.5%
AEM | $52.8 0.02% 940K twitter stocktwits trandingview |
Non-Energy Minerals
| | O: 1.27% H: 2.11% C: 1.42%
PAAS | $17.015 0.03% 1.1M twitter stocktwits trandingview |
Non-Energy Minerals
| | O: -0.88% H: 4.76% C: 3.76%

approval
Axonics Receives FDA Approval for Fourth-Generation Rechargeable Sacral Neuromodulation System
Published: 2023-01-31 (Crawled : 14:00) - biospace.com/
AXNX M | $58.19 -1.09% 130K twitter stocktwits trandingview |
Health Technology
| | O: 0.55% H: 0.0% C: 0.0%

fda system for axonics approval
Arcturus Therapeutics Announces Clinical Trial Application for ARCT-032 Received Approval to Proceed into First-in-Human Studies to Treat Cystic Fibrosis
Published: 2023-01-31 (Crawled : 14:00) - biospace.com/
ARCT | $20.04 -4.8% 110K twitter stocktwits trandingview |
Health Technology
| | O: -0.64% H: 4.14% C: 4.14%

arct-032 fibrosis for application trial approval therapeutics
Context Therapeutics’ Clinical Partner Stemline Therapeutics, a Subsidiary of Menarini Group Receives FDA Approval of ORSERDU™ (elacestrant) in ER+, HER2-, ESR1-mutated Breast Cancer
Published: 2023-01-31 (Crawled : 13:20) - biospace.com/
CNTX | $0.9688 130K twitter stocktwits trandingview |
Health Technology
| | O: 74.29% H: 27.05% C: -13.11%

fda breast approval cancer group elascestrant orserdu ona-xr her2-
HomeTrust Bancshares, Inc. Announces Regulatory Approval for Merger with Quantum Capital Corp.
Published: 2023-01-31 (Crawled : 13:20) - globenewswire.com
HTBI M | $27.8 -0.64% 37K twitter stocktwits trandingview |
Finance
| | O: 0.8% H: 1.85% C: 1.85%

quantum for approval
Gainers vs Losers
54% 46%

Top 10 Gainers
DGLY | News | $5.43 1722.15% 160K twitter stocktwits trandingview |
Electronic Technology

CELZ | $1.115 115.54% 120M twitter stocktwits trandingview |

AVRO | $1.78 104.01% 11M twitter stocktwits trandingview |
Health Technology

GFAI | $0.4936 44.54% 62M twitter stocktwits trandingview |

KPRX | News | $6.43 41.32% 16M twitter stocktwits trandingview |
Manufacturing

WETG | $0.551 34.39% 13M twitter stocktwits trandingview |

PRFX | $0.65 30.0% 13M twitter stocktwits trandingview |
Health Technology

BBLG | $0.3799 20.76% 740K twitter stocktwits trandingview |
n/a

NEWR A | $77.25 19.62% 2.7M twitter stocktwits trandingview |
Technology Services

THCH | $4.99 18.81% 560K twitter stocktwits trandingview |
n/a


Your saved searches
Save your searches and get alerts when important news are released.